TY - JOUR
T1 - Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein
T2 - Journal of Medicinal Chemistry
AU - Jabeen, I.
AU - Pleban, K.
AU - Rinner, U.
AU - Chiba, P.
AU - Ecker, G.F.
N1 - © 2012 American Chemical Society
PY - 2012/3/27
Y1 - 2012/3/27
N2 - The drug efflux pump P-glycoprotein (P-gp) has been shown to promote multidrug resistance (MDR) in tumors as well as to influence ADME properties of drug candidates. Here we synthesized and tested a series of benzophenone derivatives structurally analogous to propafenone-type inhibitors of P-gp. Some of the compounds showed ligand efficiency and lipophilic efficiency (LipE) values in the range of compounds which entered clinical trials as MDR modulators. Interestingly, although lipophilicity plays a dominant role for P-gp inhibitors, all compounds investigated showed LipE values below the threshold for promising drug candidates. Docking studies of selected analogues into a homology model of P-glycoprotein suggest that benzophenones show an interaction pattern similar to that previously identified for propafenone-type inhibitors.
AB - The drug efflux pump P-glycoprotein (P-gp) has been shown to promote multidrug resistance (MDR) in tumors as well as to influence ADME properties of drug candidates. Here we synthesized and tested a series of benzophenone derivatives structurally analogous to propafenone-type inhibitors of P-gp. Some of the compounds showed ligand efficiency and lipophilic efficiency (LipE) values in the range of compounds which entered clinical trials as MDR modulators. Interestingly, although lipophilicity plays a dominant role for P-gp inhibitors, all compounds investigated showed LipE values below the threshold for promising drug candidates. Docking studies of selected analogues into a homology model of P-glycoprotein suggest that benzophenones show an interaction pattern similar to that previously identified for propafenone-type inhibitors.
KW - Benzophenones
KW - Binding Sites
KW - Cell Line, Tumor
KW - Crystallography, X-Ray
KW - Drug Resistance, Multiple
KW - Drug Resistance, Neoplasm
KW - Drug Screening Assays, Antitumor
KW - Ether-A-Go-Go Potassium Channels
KW - Humans
KW - Ligands
KW - Models, Molecular
KW - Molecular Conformation
KW - P-Glycoprotein
KW - Propafenone
KW - Quantitative Structure-Activity Relationship
KW - Serotonin Plasma Membrane Transport Proteins
KW - Structure-Activity Relationship
KW - 1 [2 [3 [4 [3 (2 benzoyl phenoxy) 2 hydroxyl propyl]piperazin 1 yl] 2 hydroxy propoxy] 5 methyl phenyl]ethanone
KW - 4 [3 (2 benzoyl phenoxy) 2 hydroxy propyl]piperazine 1 carbothioic acid 4 tolylamide
KW - 4 [3 (2 benzoyl phenoxy) 2 hydroxy propyl]piperazine 1 carboxylic acid 4 tolylamide
KW - 4 hydroxy 4 phenyl piperidine
KW - [2 (2 hydroxy 3 morpholin 4 yl propoxy)phenyl]phenyl methanone
KW - [2 [3 [4 (2,3 xylyl)piperazin 1 yl] 2 hydroxy propoxy]phenyl]phenyl methanone
KW - [3 (2 hydroxy 3 piperidin 1 yl propoxy)phenyl]phenyl methanone
KW - [3 [2 hydroxy 3 (4 o tolyl piperazin 1 yl)propoxy]phenyl]phenyl methanone
KW - [3 [3 [4 (2,3 xylyl)piperazin 1 yl] 2 hydroxy propoxy]phenyl]phenyl methanone
KW - [3 [3 [4 (4 fluoro phenyl)piperazin 1 yl] 2 hydroxy propoxy]phenyl]phenyl methanone
KW - [4 (2 hydroxy 3 morpholin 4 yl propoxy)phenyl]phenyl methanone
KW - [4 (2 hydroxy 3 piperidin 1 yl propoxy)phenyl]phenyl methanone
KW - [4 [2 hydroxy 3 (4 o tolyl piperazin 1 yl) propoxy]phenyl]phenyl methanone
KW - [4 [3 [4 (2,3 xylyl)piperazin 1 yl] 2 hydroxy propoxy]phenyl]phenyl methanone
KW - [4 [3 [4 (4 fluoro phenyl)piperazin yl] 2 hydroxy propoxy]phenyl]phenyl methanone
KW - benzophenone derivative
KW - cyclosporin A
KW - elacridar
KW - glycoprotein P inhibitor
KW - gpv 005
KW - gpv 062
KW - gpv 576
KW - niguldipine
KW - ont 093
KW - propafenone
KW - tariquidar
KW - unclassified drug
KW - valspodar
KW - verapamil
KW - zosuquidar
KW - article
KW - drug efficacy
KW - lipophilicity
KW - molecular docking
KW - structural homology
KW - structure activity relation
KW - Benzophenones/chemical synthesis
KW - ERG1 Potassium Channel
KW - ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors
KW - Ether-A-Go-Go Potassium Channels/antagonists & inhibitors
KW - Serotonin Plasma Membrane Transport Proteins/metabolism
KW - Propafenone/analogs & derivatives
KW - Drug Resistance, Neoplasm/drug effects
KW - Drug Resistance, Multiple/drug effects
UR - http://www.scopus.com/inward/record.url?scp=84859793608&partnerID=8YFLogxK
U2 - 10.1021/jm201705f
DO - 10.1021/jm201705f
M3 - Article
C2 - 22452412
SN - 1520-4804
VL - 55
SP - 3261
EP - 3273
JO - J. Med. Chem.
JF - J. Med. Chem.
IS - 7
ER -